In Reply
- PMID: 29189684
- DOI: 10.1097/AOG.0000000000002385
In Reply
Comment on
-
Tranexamic Acid for the Management of Obstetric Hemorrhage.Obstet Gynecol. 2017 Oct;130(4):765-769. doi: 10.1097/AOG.0000000000002253. Obstet Gynecol. 2017. PMID: 28885402
-
Tranexamic Acid for the Management of Obstetric Hemorrhage.Obstet Gynecol. 2017 Dec;130(6):1386. doi: 10.1097/AOG.0000000000002384. Obstet Gynecol. 2017. PMID: 29189683 No abstract available.
References
-
- Pacheco LD, Hankins GVD, Saad AF, Costantine MM, Chiossi G, Saade GR. Tranexamic acid for the management of obstetrical hemorrhage. Obstet Gynecol 2017;130:765–9.
-
- Postpartum hemorrhage. Practice Bulletin No. 183. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e168–86.
-
- World Health Organization. WHO recommendations for the prevention and treatment of postpartum hemorrhage. Geneva (Switzerland): World Health Organization; 2012.
-
- Kruithof EK, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987;69:460–6.
-
- Ducloy-Bouthors AS, Duhamel A, Kipnis E, Tournoys A, Prado-Dupont A, Elkalioubie A, et al. Postpartum hemorrhage related early increase in D-dimers is inhibited by tranexamic acid: hemostasis parameters of a randomized controlled open label trial. Br J Anaesth 2016;116:641–8.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources